Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization

American Journal of Gastroenterology

Volumn 95, Issue 3, 2000, Pages 788-792

  Henke, Curtis J ^a,b   Levin, Theodore R ^d   Henning, James M ^c   Potter, Lori P ^a  

^a Lewin TAG Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAP Holdings Inc   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; EMPLOYMENT; GASTROESOPHAGEAL REFLUX; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL; PRODUCTIVITY;

ABSENTEEISM; ADULT; CALIFORNIA; COSTS AND COST ANALYSIS; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; SICK LEAVE; SICKNESS IMPACT PROFILE;

EID: 0033993658     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00920-X     Document Type: Article

References (9)

1. Levin T.R., Schmittdiel J.A., Kunz K., et al. Costs of acid-related disorders to a health maintenance organization. Am J Med. 103:1997;520-528.
2. Sonnenberg A., Schwartz J.S., Cutler A.F., et al. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies. Arch Intern Med. 158:1998;852-860.
3. Sonnenberg A., Everhart E. Health impact of peptic ulcer in the United States. Am J Gastroenterol. 92:1997;614-620.
4. Reilly T.G., Ayres R.C., Poxon V., et al. Helicobacter pylori eradication in a clinical setting Success rates and the effect on the quality of life in peptic ulcer . Aliment Pharmacol Ther. 9:1995;483-490.
5. Ruszniewski P. Pharmacoeconomic considerations in the long-term management of peptic ulcer disease. Aliment Pharmacol Ther. 7:(suppl):1993;2:41-2:48.
6. Levin T.R., Schmittdiel J.A., Henning J.M., et al. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization. Am J Gastroenterol. 93:1998;743-747.
7. Gold M.R., Siegel J.E., Russell L.B., et al. Cost-effectiveness in health, and medicine. 1996;Oxford University Press, New York.
8. Koopmanschap M.A., Rutten F.F.H. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 10:1996;460-466.
9. Rothermich E.A., Pathak D.S. Productivity-cost controversies in cost-effectiveness analysis Review and research agenda . Clin Ther. 21:1999;255-267.